Tetanus Toxoid Chiron

Tetanus Toxoid Statens

Tetanus Toxoid Berna

Tetanus Toxoid BioPort

Tetanus Toxoid Lederle

Pharmaceutical Research: Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid

Type: Original PaperPurposeExposure of tetanus toxoid to moisture leads to its aggregation and reduction of potency. The aim of this work was to use SELEX (systematic evolution of ligands by exponenti...

CDC: Give Tdap During Every Pregnancy (CME/CE)

(MedPage Today) -- Women should receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine during every pregnancy -- regardless of vaccination history -- to help pro...

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older—Advisory Committee on Immunization Practices (ACIP), 2012

Morbidity and Mortality Weekly Report Volume Number: 308, Issue Number: 10, First Page: 968, Last Page: 970

FDA approves GSK MenHibrix vaccine

The FDA has approved GlaxoSmithKline's (GSK) MenHibrix, meningococcal groups C and Y and Haemophilus b Tetanus toxoid conjugate vaccine.

GSK receives FDA approval for MenHibrix

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix® [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vacci...

FDA approves GSK’s MenHibrix to treat meningococcal and Hib diseases

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine...

New African monkey species identified

Researchers have identified a new species of African monkey, locally known as the lesula, described in the Sep. 12 issue of the open access journal PLOS ONE. This is only the second new species of Af...

GSK Receives FDA Approval for MenHibrix®

PHILADELPHIA, June 14, 2012 /- GlaxoSmithKline plc (NYSE: GSK ) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix® [Meningococcal Groups C...

Accelerated Stability Studies for Moisture-Induced Aggregation of Tetanus Toxoid.

PURPOSE: The study was carried out to evaluate the effect of exposing solid tetanus toxoid to moisture in two different ways on the structure and function of the toxoid. METHODS: Tetanus toxoid was ex...

Detection of anti-tetanus toxoid antibody on modified polyacrylonitrile fibers.

Accurate determination of concentration of immunoglobulin (IgG) to tetanus toxoid is important in order to evaluate the immunogenicity of tetanus toxoid vaccines, immune competence in individual patie...

Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.

The aggregation of tetanus toxoid leads to reduced bioavailability of the vaccine and failure of immunization programmes in many parts of the globe. One of the main reasons for denaturation and aggreg...

Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (tdap) in an emergency department - Arizona, 2009-2010.

Because of an increasing incidence of reported pertussis cases attributed to waning immunity among adults and adolescents, the Advisory Committee on Immunization Practices (ACIP) in 2005 recommended a...

Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was not licensed for use in adults aged ≥65 years due to lack of sufficient efficacy and safety data.